• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩大进行性家族性肝内胆汁淤积症的谱系:3例报告

Expanding the spectrum of progressive familial intrahepatic cholestasis: A report of 3 cases.

作者信息

Jiao Jingjing, Morotti Raffaella, Shafizadeh Nafis, Jain Dhanpat

机构信息

Department of Pathology, Yale School of Medicine, New Haven, CT, US.

Department of Pathology, Southern California Permanente Medical Group, Woodland Hills Medical Center, Los Angeles, CA, US.

出版信息

Am J Clin Pathol. 2025 Mar 8;163(3):332-339. doi: 10.1093/ajcp/aqae123.

DOI:10.1093/ajcp/aqae123
PMID:39333837
Abstract

OBJECTIVES

Progressive familial intrahepatic cholestasis (PFIC) is a group of autosomal recessive disorders caused by defects in bile secretion or transport usually presenting as cholestasis in pediatric age. Herewith, we describe 3 PFIC cases with diagnostic challenges and highlight the role of genetic analysis.

METHODS

The clinical history, laboratory data, liver biopsy, and molecular analysis for each case were reviewed.

RESULTS

Case 1, a Hispanic male from Puerto Rico with hepatomegaly since age 2 months, was eventually diagnosed with PFIC3 following identification of a homozygous splice site variant in ATP binding cassette subfamily B member 4 (ABCB4) (c.2784-12T>C) at age 17 years by whole-exome sequencing (WES). Case 2 was a 37-year-old man with a history of alcoholism, abnormal liver function tests, and ductopenia on biopsy. Molecular testing revealed a pathogenic heterozygous ABCB4 mutation (c.1633C>T) variant leading to a diagnosis of PFIC3. Case 3 was a 2-year-old female initially presenting as a drug-induced liver injury but was diagnosed with PFIC10 following identification of a heterozygous frameshift mutation (p.Asp300Trpfs*19) and a heterozygous missense mutation (c.1357T>C) in myosin VB (MYO5B) by WES.

CONCLUSIONS

These PFIC cases highlight the heterogenous presentation and diagnostic challenges, and they emphasize the role of next-generation sequencing, particularly the utility of WES.

摘要

目的

进行性家族性肝内胆汁淤积症(PFIC)是一组常染色体隐性疾病,由胆汁分泌或运输缺陷引起,通常在儿童期表现为胆汁淤积。在此,我们描述3例具有诊断挑战的PFIC病例,并强调基因分析的作用。

方法

回顾了每个病例的临床病史、实验室数据、肝活检和分子分析。

结果

病例1是一名来自波多黎各的西班牙裔男性,自2个月大起出现肝肿大,17岁时通过全外显子组测序(WES)在ATP结合盒亚家族B成员4(ABCB4)中鉴定出纯合剪接位点变异(c.2784-12T>C)后,最终被诊断为PFIC3。病例2是一名37岁男性,有酗酒史、肝功能检查异常和活检显示胆管减少。分子检测发现致病性杂合ABCB4突变(c.1633C>T)变异,导致诊断为PFIC3。病例3是一名2岁女性,最初表现为药物性肝损伤,但通过WES在肌球蛋白VB(MYO5B)中鉴定出杂合移码突变(p.Asp300Trpfs*19)和杂合错义突变(c.1357T>C)后,被诊断为PFIC10。

结论

这些PFIC病例突出了其临床表现的异质性和诊断挑战,并强调了下一代测序的作用,特别是WES的实用性。

相似文献

1
Expanding the spectrum of progressive familial intrahepatic cholestasis: A report of 3 cases.扩大进行性家族性肝内胆汁淤积症的谱系:3例报告
Am J Clin Pathol. 2025 Mar 8;163(3):332-339. doi: 10.1093/ajcp/aqae123.
2
Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.马拉利昔巴特治疗进行性家族性肝内胆汁淤积症(MARCH-PFIC):一项多中心、随机、双盲、安慰剂对照的 3 期临床试验。
Lancet Gastroenterol Hepatol. 2024 Jul;9(7):620-631. doi: 10.1016/S2468-1253(24)00080-3. Epub 2024 May 6.
3
Association between ABCB4 variants and intrahepatic cholestasis of pregnancy.ABCB4基因变异与妊娠期肝内胆汁淤积症之间的关联。
Sci Rep. 2025 Jan 26;15(1):3300. doi: 10.1038/s41598-025-87909-5.
4
Progressive familial intrahepatic cholestasis type 3: Report of four clinical cases, novel ABCB4 variants and long-term follow-up.进行性家族性肝内胆汁淤积症 3 型:4 例临床病例报告、新的 ABCB4 变异体和长期随访。
Ann Hepatol. 2021 Nov-Dec;25:100342. doi: 10.1016/j.aohep.2021.100342. Epub 2021 Mar 20.
5
Generation of an iPSC line (DPNJMUi002-A) from a progressive familial intrahepatic cholestasis 3 (PFIC3) patient with a heterozygous mutation in the ABCB4 gene.从一名ABCB4基因杂合突变的进行性家族性肝内胆汁淤积症3型(PFIC3)患者中生成诱导多能干细胞系(DPNJMUi002-A)。
Stem Cell Res. 2025 Sep;87:103745. doi: 10.1016/j.scr.2025.103745. Epub 2025 Jun 5.
6
Genetic Variants and Long-Term Outcomes in Korean Children with Progressive Familial Intrahepatic Cholestasis.韩国进行性家族性肝内胆汁淤积症儿童的基因变异与长期预后
Pediatr Gastroenterol Hepatol Nutr. 2025 Jul;28(4):245-255. doi: 10.5223/pghn.2025.28.4.245. Epub 2025 Jul 7.
7
Non-syndromic perspective on a unique progressive familial intrahepatic cholestasis variant: mutation.非综合征视角下独特的进行性家族性肝内胆汁淤积症变异:突变。
Turk J Pediatr. 2024 Oct 7;66(4):505-510. doi: 10.24953/turkjpediatr.2024.4655.
8
One Family with Cholestasis: The Twisted Road to the Diagnosis of Pfic 3-Three Case Reports.一例胆汁淤积症家族:PFIC 3诊断的曲折之路——三例病例报告
Reports (MDPI). 2025 Mar 17;8(1):33. doi: 10.3390/reports8010033.
9
Lipolysis-Stimulated Lipoprotein Receptor Gene Variants as a Cause of Progressive Familial Intrahepatic Cholestasis: A Case Report.脂解刺激脂蛋白受体基因变异作为进行性家族性肝内胆汁淤积症的病因:一例报告
Hepatol Res. 2025 Jul 18. doi: 10.1111/hepr.70003.
10
[Clinical and genetic analysis of a Chinese pedigree with autosomal recessive familial intrahepatic cholestasis type I due to a novel variant of ATP8B1 gene].[ATP8B1基因新变异致常染色体隐性遗传I型家族性肝内胆汁淤积症一家系的临床及遗传学分析]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2025 May 10;42(5):608-612. doi: 10.3760/cma.j.cn511374-20241224-00680.